v3.25.1

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Assets
Cash and cash equivalents	$ 188	$ 549
Accounts receivable, net of allowance for credit losses of $25 and $29 as of March 31, 2025 and December 31, 2024, respectively	1,404	1,304
Inventories	189	188
Prepaid expenses and other current assets	294	351
Total current assets	2,075	2,392
Property, plant and equipment, net	2,098	2,113
Operating lease right-of-use assets	656	651
Goodwill	8,849	8,856
Intangible assets, net	1,725	1,763
Investments in equity method investees	134	123
Other assets	260	255
Total assets	15,797	16,153
Current liabilities:
Accounts payable and accrued expenses	1,267	1,394
Current portion of long-term debt	1	602
Current portion of long-term operating lease liabilities	173	173
Total current liabilities	1,441	2,169
Long-term debt	5,858	5,615
Long-term operating lease liabilities	538	535
Other liabilities	917	938
Commitments and contingencies
Redeemable noncontrolling interest	81	83
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2025 and December 31, 2024; 162 shares issued as of both March 31, 2025 and December 31, 2024	2	2
Additional paid-in capital	2,310	2,361
Retained earnings	9,490	9,360
Accumulated other comprehensive loss	(83)	(88)
Treasury stock, at cost; 50 and 51 shares as of March 31, 2025 and December 31, 2024, respectively	(4,790)	(4,857)
Total Quest Diagnostics stockholders’ equity	6,929	6,778
Noncontrolling interests	33	35
Total stockholders’ equity	6,962	6,813
Total liabilities and stockholders’ equity	$ 15,797	$ 16,153

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

QUEST DIAGNOSTICS INC 10-Q